Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2012 by Dubai Health Authority
Sponsor:
Information provided by (Responsible Party):
Sivakami A Pai, Dubai Health Authority
ClinicalTrials.gov Identifier:
NCT01707745
First received: September 22, 2012
Last updated: October 15, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)